Exploratory analysis of target concentration of lenvatinib in the treatment of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Exploratory analysis of target concentration of lenvatinib in the treatment of hepatocellular carcinoma

Published:2021-04-29 Issue:2 Volume:88 Page:281-288
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Noda Satoshi^ORCID,Iida Hiroya,Fujimoto Takehide,Wakasugi Yoshinori,Yabuta Naoki,Sudou Masatomo,Hira Daiki,Tani Masaji,Andoh Akira,Morita Shin-ya,Terada Tomohiro

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-021-04286-2.pdf

Reference16 articles.

1. Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F et al (2018) Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet 391:1163–1173

2. Ikeda K, Kudo M, Kawazoe S, Osaki Y, Ikeda M, Okusaka T et al (2017) Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma. J Gastroenterol 52:512–519

3. Tamai T, Hayato S, Hojo S, Suzuki T, Okusaka T, Ikeda K et al (2017) Dose finding of lenvatinib in subjects with advanced hepatocellular carcinoma based on population pharmacokinetic and exposure-response analyses. J Clin Pharmacol 57:1138–1147

4. Gao B, Yeap S, Clements A, Balakrishnar B, Wong M, Gurney H (2012) Evidence for therapeutic drug monitoring of targeted anticancer therapies. J Clin Oncol 30:4017–4025

5. Verheijen RB, Yu H, Schellens JHM, Beijnen JH, Steeghs N, Huitema ADR (2017) Practical recommendations for therapeutic drug monitoring of kinase inhibitors in oncology. Clin Pharmacol Ther 102:765–776

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relevance of plasma lenvatinib concentrations and endogenous urinary cytochrome P450 3A activity biomarkers in clinical practice;Pharmacology Research & Perspectives;2024-07-11

2. A developed and validated centrifugal ultrafiltration coupled with high performance liquid chromatography-tandem mass spectrometry method for rapid quantification of unbound lenvatinib in human plasma;Journal of Chromatography B;2024-06

3. Simultaneous determination of 11 oral targeted antineoplastic drugs and 2 active metabolites by LC-MS/MS in human plasma and its application to therapeutic drug monitoring in cancer patients;Journal of Chromatography B;2024-04

4. Management of high-alert medications by clinical pharmacological approaches;Folia Pharmacologica Japonica;2024-03-01

5. Effects of diet and gender on the pharmacokinetics of oral lenvatinib: A clinical trial in healthy Chinese participants;Int. Journal of Clinical Pharmacology and Therapeutics;2023-11-01